MIR
What one share of Mirion Technologies holds
Measuring and Controlling Devices, NEC
At Mirion, we deliver vital protection that unlocks the transformative potential of radiation to move science, industry and medicine forward. For more than 60 years Mirion and our predecessor companies have provided products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience.
Mirion Technologies’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.70 |
|---|---|
| Profit | $0.09 |
| Capex (buildings and equipment) | $0.14 |
| Free cash flow | $0.48 |
| Cash and investments | $1.71 |
| Debt | $1.82 |
| Book value | $7.47 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | $69.86 | −$19.37 | $2.62 | −$0.29 | — | $0.00 |
| 2020 | $74.11 | −$18.46 | $3.08 | $3.04 | — | −$111.37 |
| 2021 | $93.39 | −$24.17 | $3.54 | $4.64 | — | −$128.51 |
| 2022 | $3.96 | −$1.53 | $0.19 | $0.03 | — | $7.72 |
| 2023 | $4.08 | −$0.49 | $0.19 | $0.30 | — | — |
| 2024 | $4.20 | −$0.18 | $0.24 | $0.25 | — | $7.34 |
| 2025 | $3.54 | $0.11 | $0.14 | $0.41 | — | $8.12 |